Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures

P Pushko, P Pumpens, E Grens - Intervirology, 2013 - karger.com
Virus-like particle (VLP) technology is a promising approach for the construction of novel
vaccines, diagnostic tools, and gene therapy vectors. Initially, VLPs were primarily derived …

African horse sickness: A review of current understanding and vaccine development

SJ Dennis, AE Meyers, II Hitzeroth, EP Rybicki - Viruses, 2019 - mdpi.com
African horse sickness is a devastating disease that causes great suffering and many
fatalities amongst horses in sub-Saharan Africa. It is caused by nine different serotypes of …

Insect cell technology is a versatile and robust vaccine manufacturing platform

JA Mena, AA Kamen - Expert review of vaccines, 2011 - Taylor & Francis
Baculovirus and insect cell culture technologies have mostly been limited to research
laboratories for the transient expression of target proteins for drug development purposes …

Virus-like particles produced in plants as potential vaccines

N Scotti, EP Rybicki - Expert review of vaccines, 2013 - Taylor & Francis
Virus-like particles (VLPs) have been produced as candidate vaccines in plants virtually
since the introduction of biofarming. Even today, VLPs remain the best candidates for safe …

Insect cells as a production platform of complex virus-like particles

F Fernandes, AP Teixeira, N Carinhas… - Expert review of …, 2013 - Taylor & Francis
Virus-like particles (VLPs) are multiprotein structures that resemble the conformation of
native viruses but lack a viral genome, potentiating their application as safer and cheaper …

Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge

E Matsuo, CCP Celma, M Boyce, C Viarouge… - Journal of …, 2011 - Am Soc Microbiol
The reverse genetics technology for bluetongue virus (BTV) has been used in combination
with complementing cell lines to recover defective BTV-1 mutants. To generate a potential …

Prospects of next-generation vaccines for bluetongue

PA Van Rijn - Frontiers in Veterinary Science, 2019 - frontiersin.org
Bluetongue (BT) is a haemorrhagic disease of wild and domestic ruminants with a huge
economic worldwide impact on livestock. The disease is caused by BT-virus transmitted by …

Current strategies for subunit and genetic viral veterinary vaccine development

A Brun, J Bárcena, E Blanco, B Borrego, D Dory… - Virus research, 2011 - Elsevier
Developing vaccines for livestock provides researchers with the opportunity to perform
efficacy testing in the natural hosts. This enables the evaluation of different strategies …

Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations

F Feenstra, PA Van Rijn - Critical reviews in microbiology, 2017 - Taylor & Francis
Bluetongue virus (BTV) causes the hemorrhagic disease bluetongue (BT) in ruminants. The
best way to control outbreaks is vaccination. Currently, conventionally modified-live and …

Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system

SW Metz, GP Pijlman - Journal of Invertebrate Pathology, 2011 - Elsevier
The baculovirus-insect cell expression system is a well-established technology for the
production of heterologous viral (glyco) proteins in cultured cells, applicable for basic …